11
Views
0
CrossRef citations to date
0
Altmetric
Correspondence

Systemic mastocytosis associated with acute myeloid leukaemia

&
Pages 485-487 | Published online: 15 Jul 2010

  • Horny HP, Metcalfe DD, Bennett JM, Bain BJ. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, et al, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2008.
  • Gardin C, Turlure P, Fagot T. Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomised Acute Leukemia French Association (ALFA) 9083 trial. Blood 2007; 109: 5129–5135.
  • Pullarkat V, Bueso-Ramos C, Lai R, et al Systemic mastocytosis with associated clonal haematological non-mast-cell lineage disease: analysis of clinicopathological features and activating c-kit mutations. Am J Hematol 2003; 73: 12–17.
  • Sperr W, Horny H-P, Lechner K, Valent P. Clinical and biological diversity of leukemias occurring in patients with mastocytosis. Leuk Lymphoma 2000; 37: 473–486.
  • Horny H-P, Sotlar K, Sperr W, Valent P. Systemic mastocytosis with associated clonal haematological non-mast cell lineage disease: a histopathological challenge. J Clin Pathol 2004; 57: 604–608.
  • Sperr W, Horny H-R, Valent P. Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis. Int Arch Allergy Immunol 2002; 127: 140–142.
  • Escribano L, Garcia-Montero A, Nunez-Lopez R, et al Systemic mastocytosis associated with acute myeloid leukemia: case report and implications for disease pathogenesis. J Allergy Clin Immunol 2004; 114: 28–33.
  • Bernd H-W, Sotlar K, Lorenzen J, Osieka R, et al Acute myeloid leukemia with t(8;21) associated with ‘occult’ mastocytosis. Report of an unusual case and review of the literature. J Clin Pathol 2003; 57: 324–328.
  • Sperr W, Jordan J-H, Baghestanian M, et al Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 2001; 98: 2200–2209.
  • Ustun C, Corless C, Savage N, et al Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KITD816V. Leuk Res 2009; 33: 735–741.
  • Sperr W, Walchshofer S, Horny H-P, et al Systemic mastocytosis associated with acute myeloid leukemia: report of two cases and detection of the c-kit mutation Asp–816 to Val. Br J Haematol 1998; 103: 740–749.
  • Akin C, Kirshenbaum A, Semere T, et al Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Exp Hematol 2000; 28: 140–147.
  • Pullarkat V, Bedell V, Kim Y, et al Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone. Leuk Res 2007; 31: 261–265.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.